Aridis Pharmaceuticals Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Aridis Pharmaceuticals Inc.
Quantité totale PI 26
Quantité totale incluant filiales 29 (+ 3 pour les filiales)
Rang # Quantité totale PI 57 329
Note d'activité PI 1,6/5.0    7
Rang # Activité PI 135 566
Symbole boursier ARDS (nasdaq)
ISIN US0403341045
Capitalisation 58.90M  (USD)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

17 0
3 0
6 0
0
 
Dernier brevet 2024 - Methods of enhancing and expedit...
Premier brevet 2010 - Gallium formulation for the trea...

Filiales

2 subsidiaries with IP (3 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Derniers inventions, produits et services

2022 Invention Tunable transposon systems. This invention provides methods and systems for enhancement of prote...
2021 Invention Tunable transposon systems. This invention provides methods and systems for enhancement of protei...
2020 Invention Methods of enhancing and expediting expression of antibodies. This application describes cells, ...
Invention Methods of enhancing and expediting expression of antibodies. This application describes cells, s...
Invention Thermostable quick-dissolving thin film. The present invention relates to thermostable quick-diss...
Invention Thermostable quick-disolving thin film. The present invention relates to thermostable quick-disso...
2019 Invention Acinetobacter baumannii . Acinetobacter and compositions comprising these polypeptides. The inven...
2018 Invention Compositions and methods against p. aeruginosa infections. A combination of an antibody and othe...
Invention Compositions and methods against p. aeruginosa infections. A combination of an antibody and other...
Invention Targets of acinetobacter baumannii. Acinetobacter and compositions comprising these polypeptides....
Invention Acinetobacter baumannii. Acinetobacter and compositions comprising these polypeptides. The invent...
2017 Invention Method for preparation of quick dissolving thin films containing bioactive material with enhanced...
2015 Invention Human monoclonal antibody specific for the f protein of respiratory syncytial virus (rsv). −9M. P...
Invention Human monoclonal antibody specific for the f protein of respiratory syncytial virus (rsv). This i...
2014 Invention Human monoclonal antibody specific for the f protein of respiratory syncytial virus (rsv). −9 M. ...
2010 Invention S. aureus derived alpha-toxin and its use in treating or preventing abscess formation. S. aureus,...
Invention Gallium formulation for the treatment and prevention of infectious diseases. Pseudomonas aerugino...